Pharmacokinetic-pharmacodynamic modeling of opioids

Journal of Pain and Symptom Management

Volumn 29, Issue 5 SUPPL., 2005, Pages 90-103

  Lötsch, Jörn ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Concentration response relationship; Effect compartment; Pain therapy; Population modeling

Indexed keywords

ALFENTANIL; FENTANYL; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; MORPHINE SULFATE; OPIATE; PIRITRAMIDE; REMIFENTANIL; SUFENTANIL; TREFENTANIL;

AGE DISTRIBUTION; ANALGESIA; CONCENTRATION RESPONSE; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; DRUG POTENCY; ELECTROENCEPHALOGRAPHY; HUMAN; MATHEMATICAL MODEL; PAIN ASSESSMENT; PLASMA HALF LIFE; POPULATION MODEL; PUPIL; RESPIRATION DEPRESSION; SEX DIFFERENCE; THEORETICAL MODEL; TREATMENT PLANNING;

EID: 19344374700     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.01.012     Document Type: Conference Paper

References (40)

1. A.J. Hiltunen, P. Lafolie, and J. Martel Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients Psychopharmacology (Berl) 118 1995 122 126
2. D.W. Boulton, P. Arnaud, and C.L. DeVane Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate Clin Pharmacol Ther 70 2001 48 57
3. M.S. Angst, M. Bührer, and J. Lötsch Insidious intoxication after morphine treatment in renal failure: Delayed onset of morphine-6- glucuronide action Anesthesiology 92 2000 1473 1476
4. H.S. Levin, V.M. O'Donnell, and R.G. Grossman The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury J Nerv Ment Dis 167 1979 675 684
5. D. Bourquin, T. Lehmann, and R. Hammig High-performance liquid chromatographic monitoring of intravenously administered diacetylmorphine and morphine and their metabolites in human plasma J Chromatogr B 694 1997 233 238
6. M. Gardmark, M.O. Karlsson, F. Jonsson, and M. Hammarlund-Udenaes Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling J Pharm Sci 87 1998 813 820
7. N.H. Holford, and L.B. Sheiner Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models Clin Pharmacokinet 6 1981 429 453
8. N.H. Holford, and L.B. Sheiner Pharmacokinetic and pharmacodynamic modeling in vivo CRC Crit Rev Bioeng 5 1981 273 322
9. W.A. Colburn Pharmacokinetic/pharmacodynamic modeling: what it is! J Pharmacokinet Biopharm 15 1987 545 555
10. H. Derendorf, and G. Hochhaus Handbook of pharmacokinetic/pharmacodynamic correlation 1995 CRC Press Boca Raton, London, Tokyo
11. C.J. Hull, H.B. Van Beem, and K. McLeod A pharmacodynamic model for pancuronium Br J Anaesth 50 1978 1113 1123
12. L.B. Sheiner, D.R. Stanski, and S. Vozeh Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine Clin Pharmacol Ther 25 1979 358 371
13. A. Suri, K.S. Estes, G. Geisslinger, and H. Derendorf Pharmacokinetic-pharmacodynamic relationships for analgesics Int J Clin Pharmacol Ther 35 1997 307 323
14. J.D. Unadkat, F. Bartha, and L.B. Sheiner Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models Clin Pharmacol Ther 40 1986 86 93
15. J.C. Scott, K.V. Ponganis, and D.R. Stanski EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil Anesthesiology 62 1985 234 241
16. J.C. Scott, and D.R. Stanski Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation J Pharmacol Exp Ther 240 1987 159 166
17. J.C. Scott, J.E. Cooke, and D.R. Stanski Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil Anesthesiology 74 1991 34 42
18. H.J. Lemmens, J.B. Dyck, S.L. Shafer, and D.R. Stanski Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil Clin Pharmacol Ther 56 1994 261 271
19. V. Billard, P.L. Gambus, and N. Chamoun A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect Clin Pharmacol Ther 61 1997 45 58
20. T. Bouillon, C. Schmidt, and G. Garstka Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of alfentanil Anesthesiology 91 1999 144 155
21. T.D. Egan, C.F. Minto, and D.J. Hermann Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers [published erratum appears in Anesthesiology 1996 Sep;85(3):695] Anesthesiology 84 1996 821 833
22. D.J. Hermann, T.D. Egan, and K.T. Muir Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics Clin Pharmacol Ther 65 1999 511 518
23. C.F. Minto, T.W. Schnider, and T.D. Egan Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development Anesthesiology 86 1997 10 23
24. C.F. Minto, T.W. Schnider, and S.L. Shafer Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application Anesthesiology 86 1997 24 33
25. P.S. Glass, D. Hardman, and Y. Kamiyama Preliminary pharmacokinetics and pharmacodynamics of an ultra- short-acting opioid: remifentanil (GI87084B) Anesth Analg 77 1993 1031 1040
26. J. Lötsch, and M.S. Angst The mu-opioid agonist remifentanil attenuates hyperalgesia evoked by blunt and punctuated stimuli with different potency: a pharmacological evaluation of the freeze lesion in humans Pain 102 1-2 2003 151 161
27. P.L. Gambus, K.M. Gregg, and S.L. Shafer Validation of the alfentanil canonical univariate parameter as a measure of opioid effect on the electroencephalogram Anesthesiology 83 1995 747 756
28. C.E. Inturrisi, W.A. Colburn, and R.F. Kaiko Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain Clin Pharmacol Ther 41 1987 392 401
29. C.E. Inturrisi, R.K. Portenoy, and M.B. Max Pharmacokinetic- pharmacodynamic relationships of methadone infusions in patients with cancer pain Clin Pharmacol Ther 47 1990 565 577
30. E. Sarton, E. Olofsen, and R. Romberg Sex differences in morphine analgesia: an experimental study in healthy volunteers Anesthesiology 93 2000 1245 1254 discussion 1246A
31. M. Dershwitz, J.L. Walsh, and R.J. Morishige Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers Anesthesiology 93 2000 619 628
32. D.J. Read, H. Simon, G. Brandi, and E.J. Campbell Regulation of ventilation during rebreathing at imposed respiratory frequencies Respir Physiol 2 1966 88 98
33. J. Lötsch, C. Skarke, and H. Schmidt The transfer half-life of morphine-6-beta-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers Anesthesiology 95 2001 1329 1338
34. C. Skarke, J. Darimont, and H. Schmidt Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers Clin Pharmacol Ther 73 2003 107 121
35. R. Romberg, E. Olofsen, and E. Sarton Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences Anesthesiology 100 2004 120 133
36. B.R. Murthy, G.M. Pollack, and K.L. Brouwer Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers J Clin Pharmacol 42 2002 569 576
37. D. Kietzmann, T. Bouillon, and C. Hamm Pharmacodynamic modelling of the analgesic effects of piritramide in postoperative patients Acta Anaesthesiol Scand 41 1997 888 894
38. S.L. Shafer, and J.R. Varvel Pharmacokinetics, pharmacodynamics, and rational opioid selection Anesthesiology 74 1991 53 63
39. C.L. Westmoreland, J.F. Hoke, and P.S. Sebel Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery Anesthesiology 79 1993 893 903
40. S.L. Shafer, and K.M. Gregg Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer- controlled infusion pump J Pharmacokinet Biopharm 20 1992 147 169